Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Trivitron Introduces COVIDscreen Plus ELISA Test kit for Antibody Testing of COVID-19 - The Pharma Times | Pharma & Health Care News Portal
New Launches

Trivitron Introduces COVIDscreen Plus ELISA Test kit for Antibody Testing of COVID-19

New Delhi, July 21, 2020: Ace health technology organization, Trivitron Healthcare introduces COVIDscreen Plus, an indigenously developed & manufactured ELISA test kit for the diagnosis of COVID-19 infection. The kit is designed for the qualitative detection of SARS-CoV-2 IgG, IgM and IgA antibodies. COVIDscreen Plus is approved and validated by the Indian Council of Medical Research (ICMR).

COVIDscreen Plus guarantees high diagnostic value as it offers 100% sensitivity and 99% specificity. The kit is based on the double antigen sandwich ELISA technique and makes use of blood serum/blood plasma as a sample.

The Elisa test kit, though needs to be handled by a trained or an experienced professional, offers ease-of-use to facilitate swift action and hassle-free use. The Elisa test kit features world-class quality and comes with color-coded reagents so that it can be easily identified by the laboratory technician. This feature not only saves time but also nullifies the possibility of operational errors.

COVIDscreen Plus uses high purity reagents with enhanced reactivity which considerably lowers its incubation time and offers prompt results. This Elisa test kit is intended to play a pivotal role in the mass screening of COVID-19 by all kinds of laboratories in the country. The affordable price per test of COVIDscreen Plus ELISA test kit will ensure greater acceptance, accessibility, and shall facilitate testing for one and all.

“COVIDscreen Plus is the latest entrant in COVID diagnostic kits and has been developed under the Make in India initiative. The Elisa test kit offers high diagnostics value through enhanced sensitivity & specificity and is affordable as compared to otherCOVID RT PCR diagnostic kits available in the market.” said Mr. Rajesh Patel, CEO-IVD (India) Trivitron Healthcare.

In view of the ICMR’s latest decision of allowing COVID-19 testing in all the laboratories, Trivitron’s COVIDscreen Plus ELISA test kit comes with unique ‘break apart’ wells that offers flexibility so that it can be used by large, medium &small-scale laboratories. Additionally, COVIDscreen Plus is packed in convenient pack size (96 tests per pack) and has a higher shelf life of 15 months (at specified storage conditions) that makes it an ideal testing kit for hospitals, in-house healthcare settings, clinics & laboratories, and it is perfectly fit for inter-state, &overseas transportation.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT);

Achieves significant advancement in Cancer Treatment to Enhance Quality of Life  As per the National…

18 hours ago

Two Complex Robotic Kidney Transplant Surgeries Successfully Performed at Fortis Hospital Bannerghatta Road

-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…

2 days ago

On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology Nurses

Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…

3 days ago

SOCC Unveils A New Era In Paediatric Care: Second Opinion Online Consultations For Children

Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…

6 days ago

India’s First Lady Surgeon Trained in Robotic Breast Surgery Performs Karnataka’s 1st Robotic Nipple Sparing Mastectomy

Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…

1 week ago

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

2 weeks ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420